RRx-001
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-16438-10 mg |
| CAS # | 925206-65-1 |
| Pricing | 10 mg, USD $228.0 |
| Biological Activity | RRx-001, a hypoxia-selective epigenetic agent and studied as a radio- and chem-sensitizer, triggers apoptosis and overcomes drug resistance in myeloma. RRx-001 exhibits potent anti-tumor activity with minimal toxicity[1]. RRx-001 is a dual small molecule checkpoint inhibitor by downregulating CD47 and SIRP-α[2]. RRx-001 is a potent inhibitor of G6PD and shows potent antimalarial activity[3]. |
| Purity | 99.71% |
| MWt | 268.02 |
| Formula | C₅H₆BrN₃O₅ |